Concord Drugs Q3 Results
- BSE: 538965
- NSE: -
- ISIN: INE858L01010
- Sector: Biotechnology & Drugs
BSE
79.95
1.86 (2.38%)
1.86 (2.38%)Volume2.74 K
Updated: Tue 8 Sep, 2026 | 09:15:35
NSE
This stock is not traded on NSE
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Concord Drugs Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 16.35 | 11.84 | 71.78% | 12.54 | 67.27% |
| Depreciation/ Amortization | 0.31 | 0.34 | -9.63% | 0.39 | -17.20% |
| Operating Income | 0.61 | 0.52 | -18.80% | 0.24 | -39.97% |
| Net Income | 0.22 | 0.04 | 12.73% | -0.24 | -4.32% |
| Other Operating Expenses Total | 0.42 | 0.41 | 13.58% | 0.49 | 64.92% |
| Net Income Before Taxes | 0.30 | 0.07 | 9.14% | -0.26 | -43.80% |
| Total Revenue | 16.97 | 12.36 | 65.10% | 12.78 | 57.10% |
| Selling/ General/ Admin Expenses Total | 1.24 | 0.93 | 13.04% | 1.54 | 23.21% |
| Diluted Normalized EPS | 0.16 | 0.04 | -15.79% | -0.24 | -30.43% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.